Autosomal recessive segregation of a truncating mutation of anti-mulleriantype II receptor in a family affected by the persistent mullerian duct syndrome contrasts with its dominant negative activity in vitro
L. Messika-zeitoun et al., Autosomal recessive segregation of a truncating mutation of anti-mulleriantype II receptor in a family affected by the persistent mullerian duct syndrome contrasts with its dominant negative activity in vitro, J CLIN END, 86(9), 2001, pp. 4390-4397
Anti-Mullerian hormone belongs to the TGF beta family whose members exert t
heir effects by signaling through two related serine/threonine kinase recep
tors. Mutations of the anti-Mullerian hormone type II receptor occur natura
lly, causing the persistent Mullerian duct syndrome. In a family with two m
embers with persistent Mullerian duct syndrome and one normal sibling, we d
etected two novel mutations of the anti-Mullerian hormone type II receptor
gene. One, transmitted by the mother to her three sons, is a deletion of a
single base leading to a stop codon, causing receptor truncation after the
transmembrane domain. The other, a missense mutation in the substrate-bindi
ng site of the kinase domain, is transmitted by the father to the two sons
affected by persistent Mullerian duct syndrome, indicating a recessive auto
somal transmission as in other cases of persistent Mullerian duct syndrome.
Truncating mutations in receptors of the TGF beta family exert dominant ne
gative activity, which was seen only when each of the mutant anti-Mullerian
hormone receptors was overexpressed in an anti-Mullerian hormone-responsiv
e cell line. We conclude that assessment of dominant activity in vitro, whi
ch usually involves overexpression of mutant genes, does not necessarily pr
oduce information applicable to clinical conditions, in which mutant and en
dogenous genes are expressed on a one to one basis.